University of Texas Texas AM Investment Management Co. Makes New $1.51 Million Investment in Agilent Technologies, Inc. $A

Key Points

• University of Texas Texas AM Investment Management Co. initiated a position in Agilent Technologies, buying 8,758 shares worth approximately $1.51 million in the third quarter.
• Agilent beat quarterly estimates, reporting EPS of $1.62 versus $1.49 expected and revenue of $1.88 billion versus $1.84 billion; revenue rose 8.1% year over year.
• Analysts give Agilent a consensus “Moderate Buy” rating with an average price target of $181.45. Institutional investors own 87.41% of the company’s shares.

University of Texas Texas AM Investment Management Co. bought a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,758 shares of the medical research company's stock, valued at approximately $1,509,000.

Several other institutional investors and hedge funds have also recently modified their holdings of A. Signature Equity Partners LLC boosted its stake in Agilent Technologies by 172.7% in the 3rd quarter. Signature Equity Partners LLC now owns 180 shares of the medical research company's stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Livelsberger Financial Advisory purchased a new stake in Agilent Technologies during the 3rd quarter valued at about $32,000. Markowski Investments bought a new stake in Agilent Technologies during the 2nd quarter valued at about $27,000. Cedar Mountain Advisors LLC bought a new stake in Agilent Technologies during the 1st quarter valued at about $27,000. Finally, Keating Financial Advisory Services Inc. bought a new stake in Agilent Technologies during the 2nd quarter valued at about $31,000. 87.41% of the stock is currently owned by institutional investors.

Agilent Technologies Price Performance

A opened at $174.79 on Monday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The stock has a market capitalization of $49.28 billion, a P/E ratio of 34.41, a P/E/G ratio of 2.56 and a beta of 1.24. The company's 50-day simple moving average is $165.94 and its two-hundred day simple moving average is $137.20. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $182.99.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter last year, the firm posted $1.37 EPS. The business's quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were paid a dividend of $0.2550 per share. The ex-dividend date was Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. Agilent Technologies's payout ratio is currently 20.08%.

Insiders Place Their Bets

In other news, Director Mikael Dolsten sold 634 shares of the stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares of the company's stock, valued at $745,395.12. This represents a 11.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.17% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on A. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, October 17th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Agilent Technologies in a research report on Monday, October 26th. They set a "buy" rating and a $190.00 price target for the company. Weiss Ratings upgraded shares of Agilent Technologies from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, October 8th. Citigroup upped their price objective on Agilent Technologies from $185.00 to $190.00 and gave the company a "buy" rating in a research report on Thursday, August 27th. Finally, Barclays upped their price objective on Agilent Technologies from $175.00 to $195.00 and gave the company an "overweight" rating in a research report on Wednesday, October 7th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $181.45.

Agilent Technologies Company Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.